clinical trial · NCT07608705
A Study to Assess the Effect of HRS-1301 on the Pharmacokinetics of Midazolam and Atorvastatin in Healthy Participants
Shandong Suncadia Medicine Co., Ltd.·phase1·recruiting·n = 16
HyperlipidemiasHRS-1301 TabletsAtorvastatin Calcium TabletsMidazolam oral solution
brief summary
This phase I study in healthy participants aims to assess the pharmacokinetics of midazolam and atorvastatin when administered alone and in combination with HRS-1301, and to assess the safety of HRS-1301 when administered alone and in combination with midazolam or atorvastatin.
started
Jun 8, 2026
primary completion
Aug 1, 2026
completion
Aug 1, 2026
last updated
Jun 16, 2026
official title
An Open-label, Single-arm, Fixed-sequence Phase I Clinical Trial to Evaluate the Effect of HRS-1301 Tablets on the Pharmacokinetics of Midazolam and Atorvastatin Calcium Tablets in Healthy Participants
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol